Rheumatoid arthritis molecular targets and their importance to flavonoid‐based therapy

Abstract

Rheumatoid arthritis (RA) is a progressive, chronic, autoimmune, inflammatory, and systemic condition that primarily affects the synovial joints and adjacent tissues, including bone, muscle, and tendons. The World Health Organization recognizes RA as one of the most prevalent chronic inflammatory diseases. In the last decade, there was an expansion on the available RA therapeutic options which aimed to improve patient's quality of life. Despite the extensive research and the emergence of new therapeutic approaches and drugs, there are still significant unwanted side effects associated to these drugs and still a vast number of patients that do not respond positively to the existing therapeutic strategies. Over the years, several references to the use of flavonoids in the quest for new treatments for RA have emerged. This review aimed to summarize the existing literature about the flavonoids' effects on the major pathogenic/molecular targets of RA and their potential use as lead compounds for the development of new effective molecules for RA treatment. It is demonstrated that flavonoids can modulate various players in synovial inflammation, regulate immune cell function, decrease synoviocytes proliferation and balance the apoptotic process, decrease angiogenesis, and stop/prevent bone and cartilage degradation, which are all dominant features of RA. Although further investigation is necessary to determine the effectiveness of flavonoids in humans, the available data from in vitro and in vivo models suggest their potential as new disease‐modifying anti‐rheumatic drugs. This review highlights the use of flavonoids as a promising avenue for future research in the treatment of RA.

A Comparative Study of the Inhibitory Effect of Some Flavonoids and a Conjugate of Taxifolin with Glyoxylic Acid on the Oxidative Burst of Neutrophils

“…Taking this into account, it can be assumed that DfTf may protect against oxidative stress-related pathological conditions or diseases when excessive extracellular production of ROS leads to cell and tissue damage [75]. The beneficial effects of polyphenols on such kind of diseases/pathological conditions have also been reported in the literature [134][135][136]. In particular, polyphenols are considered promising agents for treating inflammatory diseases of the GIT.…”

Abatacept: A Promising Repurposed Solution for Myocardial Infarction-Induced Inflammation in Rat Models

“…This was observed with the TUNEL assay, where an ABT 5 mg/kg dose markedly reduced the number of TUNEL-positive cells. ABT maintains the levels of Bax and Bcl-2 due to the maintained equilibrium between these two proteins that modulate the downstream pathway for activation of caspase-3 [ 35 , 36 ].…”